Your browser doesn't support javascript.
loading
Natural killer cell cytotoxicity is a predictor of outcome for patients with high risk myelodysplastic syndrome and oligoblastic acute myeloid leukemia treated with azacytidine.
Tsirogianni, Maria; Grigoriou, Eirini; Kapsimalli, Violetta; Dagla, Kleopatra; Stamouli, Maria; Gkirkas, Konstantinos; Konsta, Eve; Karagiannidou, Angeliki; Gkodopoulos, Konstantinos; Stavroulaki, Georgia; Pappa, Vassiliki; Angelopoulou, Maria; Lowdell, Mark; Tsirigotis, Panagiotis.
Afiliação
  • Tsirogianni M; Department of Hematology and Bone Marrow Transplantation, Saint Savvas Regional Cancer Hospital , Athens , Greece.
  • Grigoriou E; Department of Immunology and Histocompatibility, "Evangelismos" General Hospital , Athens , Greece.
  • Kapsimalli V; Department of Microbiology, Medical School, National and Kapodistrian University of Athens , Athens , Greece.
  • Dagla K; Hematology Division, 2nd Department of Internal Medicine, "ATTIKO" General University Hospital, National and Kapodistrian University of Athens , Athens , Greece.
  • Stamouli M; Hematology Division, 2nd Department of Internal Medicine, "ATTIKO" General University Hospital, National and Kapodistrian University of Athens , Athens , Greece.
  • Gkirkas K; Hematology Division, 2nd Department of Internal Medicine, "ATTIKO" General University Hospital, National and Kapodistrian University of Athens , Athens , Greece.
  • Konsta E; Hematology Division, 2nd Department of Internal Medicine, "ATTIKO" General University Hospital, National and Kapodistrian University of Athens , Athens , Greece.
  • Karagiannidou A; Hematology Division, 2nd Department of Internal Medicine, "ATTIKO" General University Hospital, National and Kapodistrian University of Athens , Athens , Greece.
  • Gkodopoulos K; Hematology Division, 2nd Department of Internal Medicine, "ATTIKO" General University Hospital, National and Kapodistrian University of Athens , Athens , Greece.
  • Stavroulaki G; Hematology Division, 2nd Department of Internal Medicine, "ATTIKO" General University Hospital, National and Kapodistrian University of Athens , Athens , Greece.
  • Pappa V; Hematology Division, 2nd Department of Internal Medicine, "ATTIKO" General University Hospital, National and Kapodistrian University of Athens , Athens , Greece.
  • Angelopoulou M; Department of Hematology and Bone Marrow Transplantation, Laikon General Hospital, National and Kapodistrian University of Athens , Athens , Greece.
  • Lowdell M; Institute of Immunity and Transplantation Centre for Cell, Gene & Tissue Therapeutics, Royal Free Hospital , London , UK.
  • Tsirigotis P; Hematology Division, 2nd Department of Internal Medicine, "ATTIKO" General University Hospital, National and Kapodistrian University of Athens , Athens , Greece.
Leuk Lymphoma ; 60(10): 2457-2463, 2019 10.
Article em En | MEDLINE | ID: mdl-30947589

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Células Matadoras Naturais / Leucemia Mieloide Aguda / Citotoxicidade Imunológica Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Lymphoma Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Grécia País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Células Matadoras Naturais / Leucemia Mieloide Aguda / Citotoxicidade Imunológica Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Lymphoma Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Grécia País de publicação: Estados Unidos